Dr. Jeremy Levin has resigned as president and chief executive officer of Teva Pharmaceutical Industries Ltd. The board has named Eyal Desheh, Teva’s executive vice president and chief financial officer, to fill those roles on an interim basis, effective immediately, and has formed a committee that will promptly begin to search for a permanent successor. Dr. Phillip Frost, Teva’s chairman, commented, “On behalf of the entire board of directors, I would like to thank Dr. Jeremy Levin...